OGT introduces new eco-friendly packaging

Oxford, UK – 12 March 2025. OGT, a leading global provider of genomic research and diagnostic solutions, is excited to share the introduction of their new, sustainable packaging for CytoCell^® products, an important step forward in their ongoing environmental efforts.

As the world, including scientific and clinical communities, continues to move towards more sustainable practices, OGT are continuing their own journey by redesigning packaging with biodegradable and sustainable materials. Their new packaging is now fully recyclable, helping to reduce waste and support a greener future, and benefits labs with enhanced sustainability, simplified disposal and streamlined and accessible digital documents.

As part of this initiative and OGT’s ongoing commitment to delivering top-quality products and service, they have also announced the introduction of new opaque amber tubing, which they will start phasing into the CytoCell product line.

For more information about changes to our packaging, please contact OGT

About OGT

OGT, a Sysmex Group company, is a leading global provider of clinical and diagnostic genomic solutions that are created for scientists by scientists - including CytoCell^®, CytoSure^® and SureSeq ranges of FISH, microarray and NGS products. The company is dedicated to creating products that enable researchers and clinical decision makers to reach the right care decisions for each patient, every time. OGT strives to unlock the future of genetic clinical care with a commitment to working in partnership with its customers - not only by sharing its expertise of 25 years at the forefront of genetic endeavour, but also by working closely with scientists to understand their unique challenges, and to customise its approach to meet their exact needs. Dedicated to improving clinical care, OGT believes that through partnership—together—we’ll achieve more.

CytoSure, SureSeq and myProbes^®: For Research Use Only, not for use in diagnostic procedures. CytoCell: Some products may not be available in your region.

About Sysmex Corporation

Sysmex Corporation, headquartered in Kobe, Japan, is a global leader in in vitro diagnostics. Since its foundation in 1968, Sysmex has focused on diagnostics as the core of its business, and today, it supports the health of people in over 190 countries and regions worldwide. Sysmex continues to innovate in diagnostics, and to collaboratively create unique values in the areas of personalized medicine and novel treatments, under its long-term vision of "Together for a better healthcare journey." Through its unique technology, solutions, and co-creation with various partners, Sysmex delivers new value and addresses the universal desire of people to live longer and healthier lives. The company employs more than 10,000 employees worldwide. Sysmex Corporation is listed in the Prime Market on the Tokyo Stock Exchange.

For more information about Sysmex Corporation and its affiliate companies, please visit www.sysmex.co.jp/en/.